← brief for 2026-11-03 · Transplant & xeno
Basiliximab induction and renal recovery after liver transplantation in high-risk recipients
Key takeaways
This study looked at kidney recovery in people who had liver transplants in Australia. It examined how a drug called basiliximab affected kidney function after the surgery. As a retrospective observational study, it shows a link between the drug and kidney outcomes, but not proof of cause.
Who did this work
D. Liu (The University of Melbourne) · A. Chan (Austin Hospital) · K. Tan (The University of Melbourne) · A. J. Wigg (Flinders University) · J. Ramachandran (Flinders University) · A. Majumdar (The University of Melbourne) · M. Sinclair (The University of Melbourne) · A. Testro (The University of Melbourne)
Source
Article · OpenAlex, CKD works · 2026-11-02
https://doi.org/10.3389/frtra.2026.1970957